Literature DB >> 25278567

Less Jak2 makes more platelets.

Radek C Skoda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25278567     DOI： 10.1182/blood-2014-08-596361

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Janus kinases to jakinibs: from basic insights to clinical practice.

Authors:  Massimo Gadina; Mimi T Le; Daniella M Schwartz; Olli Silvennoinen; Shingo Nakayamada; Kunihiro Yamaoka; John J O'Shea
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

Review 2.  [Janus kinase inhibitors : State of the art in clinical use and future perspectives].

Authors:  R Alten; M Mischkewitz; A-L Stefanski; T Dörner
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

3.  Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm.

Authors:  H Yao; Y Ma; Z Hong; L Zhao; S A Monaghan; M-C Hu; L J Huang
Journal:  Leukemia       Date:  2017-01-06       Impact factor: 11.528

4.  Chronic urticaria reveals JAK2V617F positive essential thrombocythemia.

Authors:  Marcello Albanesi; Marco Zurlo; Stefania Magistà; Nada Chaoul; Elena Minenna; Francesco Satriano; Danilo Di Bona; Eustachio Nettis; Maria Filomena Caiaffa; Luigi Macchia
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.664

5.  Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.

Authors:  Maxime Dougados; Désirée van der Heijde; Ying-Chou Chen; Maria Greenwald; Edit Drescher; Jiajun Liu; Scott Beattie; Sarah Witt; Inmaculada de la Torre; Carol Gaich; Terence Rooney; Douglas Schlichting; Stephanie de Bono; Paul Emery
Journal:  Ann Rheum Dis       Date:  2016-09-29       Impact factor: 19.103

6.  Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition.

Authors:  Martin E Dowty; Tsung H Lin; Michael I Jesson; Martin Hegen; David A Martin; Vaibhav Katkade; Sujatha Menon; Jean-Baptiste Telliez
Journal:  Pharmacol Res Perspect       Date:  2019-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.